Alpha Cognition Price to Free Cash Flow Ratio 2020-2024 | ACOG
Historical price to free cash flow ratio values for Alpha Cognition (ACOG) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Alpha Cognition Price to Free Cash Flow Ratio Historical Data |
Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
2024-11-13 |
5.74 |
|
inf |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|